Press release
Cardiac Biomarkers Testing Market Expected to Witness Massive Growth with a Significant CAGR of 7.77%, asserts Delveinsight
Cardiac Biomarkers Testing Market
Some of the key market players operating in the Cardiac Biomakers Testing Devices market include Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Bio-Rad Laboratories Inc, Eurolyser Diagnostica GmbH, Diagnostic Automation / Cortez Diagnostics, Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, Lepu Medical Technology (Beijing) Co. Ltd., Biosynex and others.
Click here to know more about Cardiac Biomarkers Testing Market Report: https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's "Cardiac Biomakers Testing Devices Market Share & Forecast" report will offer an in-depth understanding of the Cardiac Biomakers Testing Devices market, further benefiting the competitors or stakeholders operating in the Cardiac Biomakers Testing Devices arena.
Cardiac Biomakers Testing Device: An Overview
Cardiac biomarkers are protein molecules that are released into the blood after heart damage or heart-stress. These biomarkers act as a potential tool in the detection and diagnosis of various cardiovascular diseases.
Interested to know more about the functioning of Cardiac biomarkers testing devices:- https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Recent Developmental Activities in Cardiac Biomarkers Testing Market:
• In April 2021, Roche announced the series of five new intended uses for two key cardiac biomarkers using the Elecsys® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP).
• In 2019, Roche Diagnostics launched the VITROS high-sensitivity Troponin I assay
According to DelveInsight, the Cardiac Biomarkers Testing Devices Clinical Development market would rise rapidly throughout the forecast period due to continuous commercial and clinical development.
Key Players Proactively working in the Cardiac Biomakers Testing Device Market
In the global market for cardiac biomakers testing device key players contribute significantly to their development and are also active in mergers and acquisitions to strengthen their market position.
Some of the Cardiac Biomakers Testing Device Companies operating actively in the Cardiac Biomakers Testing Device include Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Bio-Rad Laboratories Inc, Eurolyser Diagnostica GmbH, Diagnostic Automation / Cortez Diagnostics, Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, Lepu Medical Technology (Beijing) Co. Ltd., Biosynex and others.
Learn more about the Cardiac Biomakers Testing Device, and get in-depth information: https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Cardiac Biomakers Testing Devices Market Report
• Study Period- 2019-2027
• Key Cardiac Biomakers Testing Devices Companies- Beckman Coulter Inc, Siemens Healthcare GmbH (NYSE: SHL), Abbott (NYSE: ABT), bioMérieux SA (NYSE: BMXMF), F. Hoffmann-La Roche Ltd (NYSE: ROG.SW), Thermo Fischer Scientific Inc (NYSE: TMO), Bio-Rad Laboratories Inc (NYSE: BIO), Eurolyser Diagnostica GmbH, Diagnostic Automation / Cortez Diagnostics, Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc (NYSE: CGNH), Lepu Medical Technology (Beijing) Co. Ltd., Biosynex, and several others.
• Cardiac Biomarker Testing Market by Product Type (Instruments And Reagents & Kits),
• Cardiac Biomarker Testing Market By Biomarker Type (Troponin, Creatine Kinase-MB, Natriuretic Peptide, Myoglobin, and Others]),
• Cardiac Biomarker Testing Market By Application (Acute Coronary Syndrome, Congestive Heart Failure, Myocardial Infarction, and Others)
• By End User (Hospitals, Pathology Labs, And Others), and
• By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
• Porter's Five Forces Analysis, Product Profiles, Cases Studies, KOL's Views, and Analyst's View
Request for Sample Report: https://www.delveinsight.com/sample-request/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Cardiac Biomarker Testing Market Report Introduction
2. Cardiac Biomarker Testing Market Executive Summary
3. Regulatory and Patent Analysis
4. Cardiac Biomarker Testing Market Key Factors Analysis
5. Cardiac Biomarker Testing Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Cardiac Biomarker Testing Market
7. Cardiac Biomarker Testing Market Layout
8. Cardiac Biomarker Testing Market Global Company Share Analysis - Key 3-5 Companies
9. Cardiac Biomarker Testing Market Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
For more details about the market share of Cardiac Biomakers Testing Devices, just click here @ https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Cardiac Biomarkers Testing Market Report Study
• Market size analysis for cardiac biomarker testing market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the cardiac biomarker testing market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global cardiac biomarker testing market.
• Various opportunities available for the other competitor in the cardiac biomarker testing market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current cardiac biomarker testing market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for cardiac biomarker testing market growth in the coming future?
Request for Sample Report: https://www.delveinsight.com/sample-request/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Contact Us
Ankit Nigam
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Get in touch with our team to get more detailed insights into how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions, at MedTech Consulting Solutions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarkers Testing Market Expected to Witness Massive Growth with a Significant CAGR of 7.77%, asserts Delveinsight here
News-ID: 2694647 • Views: …
More Releases from DelveInsight Business Research
Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across …
Gastric cancer is the fifth most common malignancy worldwide, with incidence varying by region and highest rates reported in Eastern Asia and Eastern Europe. Japan records the highest burden among the 7MM, with about 129,500 cases in 2024. Many patients, particularly in Western countries, are diagnosed at advanced (Stage IV) stages, while Japan detects more cases early (Stage I). In the US, around 35% present with metastatic disease at diagnosis,…
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM wi …
The Myelofibrosis market across the seven major markets (7MM) is anticipated to experience significant growth, rising from approximately USD 2,602 million in 2025 to nearly USD 5,638 million by 2034, reflecting a compound annual growth rate (CAGR) of about 9% during the forecast period.
In 2024, the market was valued at around USD 2.2 billion, with the United States leading at nearly USD 1.7 billion, far surpassing the EU4, the United…
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipelin …
An expanding portfolio of novel therapies for triple-negative breast cancer (TNBC) including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) is anticipated to significantly influence market expansion and transform the TNBC treatment landscape.
DelveInsight's Triple Negative Breast Cancer Pipeline Insight report offers an extensive evaluation of more than 165 companies and over 170 therapeutic candidates advancing through the TNBC pipeline. The…
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics an …
DelveInsight's latest Asthma Market Insights, Epidemiology, and Market Forecast - 2034 report provides an in-depth evaluation of current treatment practices, emerging asthma drugs, market share of individual therapies, and forecasted market trends across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The asthma market is expected to experience sustained growth over the next decade, supported by the launch of…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
